...

首页> 外文期刊>Obstetrical and gynecological survey >Randomized Clinical Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study EDITORIAL COMMENT

【24h】

Randomized Clinical Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study EDITORIAL COMMENT

机译：随机临床试验静脉内与腹腔化疗加上晚期卵巢癌中的贝伐单抗：NRG肿瘤学/妇科肿瘤学群体研究编辑评论

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Obstetrical and gynecological survey》 |2019年第8期|共3页
作者
Learman Lee A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学;
关键词

相似文献

外文文献
中文文献

1. Randomized Clinical Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study EDITORIAL COMMENT [J] . Learman Lee A. Obstetrical and gynecological survey . 2019,第8期

机译：随机临床试验静脉内与腹腔化疗加上晚期卵巢癌中的贝伐单抗：NRG肿瘤学/妇科肿瘤学群体研究编辑评论
2. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study [J] . Walker Joan L., Brady Mark F., Wenzel Lari, Journal of Clinical Oncology . 2019,第16期

机译：静脉内与腹膜内化疗的随机试验加上晚期卵巢癌中的Bevacizumab：NRG肿瘤学/妇科肿瘤学群体研究
3. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (vol 37, pg 1380, 2019) [J] . Walker Journal of Clinical Oncology . 2019,第25期

机译：随机试验静脉内与腹腔化疗加上晚期卵巢癌中的Bevacizumab：NRG肿瘤学/妇科肿瘤学群体研究（Vol 37，PG 1380,2019）
4. Clinical Comparison of Chemotherapy Regimens to Treat Advanced Retinoblastoma: Intra-Arterial and Intravitreal Chemotherapy Versus Intra-Arterial and Intravenous Chemotherapy [D] . Fine, Jessica. 2018

机译：化学疗法治疗晚期视网膜母细胞瘤的临床比较：动脉内和玻璃体内化疗与动脉内和静脉内化疗
5. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study [O] . Joan L. Walker, Mark F. Brady, Lari Wenzel, -1

机译：晚期卵巢癌静脉和腹腔内化疗联合贝伐单抗随机对照试验：NRG肿瘤/妇科肿瘤小组研究
6. Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study [O] . William P. Tew, Michael W. Sill, Joan L. Walker, 2018

机译：Bevacizumab Plus everolimus的随机阶段II试验与贝伐单抗单独用于复发或持续的卵巢癌，输卵管或腹膜癌：NRG肿瘤学/妇科肿瘤学群体研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号